Bax Expression Is Predictive of Favorable Clinical Outcome in Chemonaive Advanced Gastric Cancer Patients Treated with Capecitabine, Oxaliplatin, and Irinotecan Regimen

OBJECTIVE: Bax protein is a key mediator of apoptosis, and it might be related to chemosensitivity. The purpose of this study was to evaluate the prognostic role of Bax in patients with advanced gastric cancer treated with triplet chemotherapy COI regimen (capecitabine, oxaliplatin, and irinotecan)....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pietrantonio, Filippo, Biondani, Pamela, de Braud, Filippo, Pellegrinelli, Alessandro, Bianchini, Giampaolo, Perrone, Federica, Formisano, Barbara, Di Bartolomeo, Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press Inc. 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384269/
https://ncbi.nlm.nih.gov/pubmed/22741034
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak